Literature DB >> 8508508

Quantitative analysis of aflatoxin-albumin adducts.

F Z Sheabar1, J D Groopman, G S Qian, G N Wogan.   

Abstract

Quantitative exposure assessments made using biologically relevant markers will facilitate epidemiological studies of risk from environmental carcinogens. Blood proteins are readily accessible macromolecules that have been shown to be targets for activated chemical carcinogens. Serum albumin is quantitatively the most abundant target for aflatoxin B1 and the measurement of aflatoxin-serum albumin adducts has been used to detect exposed individuals. The goal of these experiments was to devise an analytical procedure that would increase the overall recovery of aflatoxin adducts in serum albumin, and thereby improve the accuracy of exposure monitoring. The method developed consisted of the following procedures. Proteins were precipitated from serum (< or = 100 microliters) with 80% ammonium sulfate, with incubation at 4 degrees C for 2 h. Following dialysis against phosphate-buffered saline (pH 7.0 for 3 h at 4 degrees C), the proteins were digested with protease (Pronase) (1:4.1 w/w enzyme:protein) for 15 h at 37 degrees C with shaking. Enzyme and other undigested proteins were precipitated with acetone (1:2 v/v, 40 min, 4 degrees C). After evaporation of the acetone under vacuum, levels of aflatoxin B1-albumin adducts were determined by radioimmunoassay carried out on 300 microliters fractions. This procedure obviated the isolation of albumin prior to analysis and reduced interference in the radioimmunoassay. High recoveries of aflatoxin B1 adducts were achieved together with a low limit of detection. The applicability of the procedure in epidemiological studies of human aflatoxin exposure was illustrated by results of analysis of aflatoxin-albumin adducts in serum samples from residents of Chongming Island, People's Republic of China.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508508     DOI: 10.1093/carcin/14.6.1203

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

1.  Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.

Authors:  C J Chen; M W Yu; Y F Liaw; L W Wang; S Chiamprasert; F Matin; A Hirvonen; D A Bell; R M Santella
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.

Authors:  J S Wang; S Abubaker; X He; G Sun; P T Strickland; J D Groopman
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

3.  Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.

Authors:  H Ahsan; L Y Wang; C J Chen; W Y Tsai; R M Santella
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

4.  Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries.

Authors:  Heather Strosnider; Eduardo Azziz-Baumgartner; Marianne Banziger; Ramesh V Bhat; Robert Breiman; Marie-Noel Brune; Kevin DeCock; Abby Dilley; John Groopman; Kerstin Hell; Sara H Henry; Daniel Jeffers; Curtis Jolly; Pauline Jolly; Gilbert N Kibata; Lauren Lewis; Xiumei Liu; George Luber; Leslie McCoy; Patience Mensah; Marina Miraglia; Ambrose Misore; Henry Njapau; Choon-Nam Ong; Mary T K Onsongo; Samuel W Page; Douglas Park; Manish Patel; Timothy Phillips; Maya Pineiro; Jenny Pronczuk; Helen Schurz Rogers; Carol Rubin; Myrna Sabino; Arthur Schaafsma; Gordon Shephard; Joerg Stroka; Christopher Wild; Jonathan T Williams; David Wilson
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.